

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 9.26225118 |
| 2 | protein-chromophore linkage (GO:0018298) | 8.91149611 |
| 3 | visual perception (GO:0007601) | 8.67551220 |
| 4 | retinal rod cell development (GO:0046548) | 8.65670311 |
| 5 | sensory perception of light stimulus (GO:0050953) | 8.57501617 |
| 6 | cellular response to light stimulus (GO:0071482) | 8.13265734 |
| 7 | photoreceptor cell differentiation (GO:0046530) | 7.28857303 |
| 8 | eye photoreceptor cell differentiation (GO:0001754) | 7.28857303 |
| 9 | detection of external stimulus (GO:0009581) | 6.97936254 |
| 10 | detection of abiotic stimulus (GO:0009582) | 6.83278872 |
| 11 | retina development in camera-type eye (GO:0060041) | 6.56965547 |
| 12 | regulation of cGMP metabolic process (GO:0030823) | 6.39288038 |
| 13 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 6.33021972 |
| 14 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.91558629 |
| 15 | regulation of cGMP biosynthetic process (GO:0030826) | 5.54239683 |
| 16 | adaptation of signaling pathway (GO:0023058) | 5.34540508 |
| 17 | cellular response to radiation (GO:0071478) | 5.26348173 |
| 18 | nonmotile primary cilium assembly (GO:0035058) | 5.23395966 |
| 19 | positive regulation of cGMP metabolic process (GO:0030825) | 5.18362596 |
| 20 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.13791195 |
| 21 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.76715012 |
| 22 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.66858447 |
| 23 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.30505843 |
| 24 | sensory perception (GO:0007600) | 4.02741556 |
| 25 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.96197550 |
| 26 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.93355910 |
| 27 | response to light stimulus (GO:0009416) | 3.86946417 |
| 28 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.79467594 |
| 29 | protein prenylation (GO:0018342) | 3.71929011 |
| 30 | prenylation (GO:0097354) | 3.71929011 |
| 31 | protein localization to synapse (GO:0035418) | 3.70121963 |
| 32 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.65401316 |
| 33 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.64967327 |
| 34 | retina layer formation (GO:0010842) | 3.60042506 |
| 35 | neuron development (GO:0048666) | 3.44035373 |
| 36 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.30891164 |
| 37 | retina homeostasis (GO:0001895) | 3.28703385 |
| 38 | short-term memory (GO:0007614) | 3.20342441 |
| 39 | behavioral response to ethanol (GO:0048149) | 3.19640359 |
| 40 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.07049576 |
| 41 | estrogen biosynthetic process (GO:0006703) | 3.02194311 |
| 42 | regulation of penile erection (GO:0060405) | 3.00996381 |
| 43 | chemosensory behavior (GO:0007635) | 2.92987486 |
| 44 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.90508920 |
| 45 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.90508920 |
| 46 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.84464206 |
| 47 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.81531297 |
| 48 | positive regulation of neurotransmitter transport (GO:0051590) | 2.80217752 |
| 49 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.79879478 |
| 50 | response to histamine (GO:0034776) | 2.78086896 |
| 51 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78068379 |
| 52 | phospholipid translocation (GO:0045332) | 2.76656802 |
| 53 | lipid translocation (GO:0034204) | 2.76656802 |
| 54 | retinoid metabolic process (GO:0001523) | 2.74161988 |
| 55 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.73215653 |
| 56 | cellular response to abiotic stimulus (GO:0071214) | 2.70431815 |
| 57 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.70261489 |
| 58 | axoneme assembly (GO:0035082) | 2.69198179 |
| 59 | membrane hyperpolarization (GO:0060081) | 2.68291509 |
| 60 | icosanoid secretion (GO:0032309) | 2.68178967 |
| 61 | arachidonic acid secretion (GO:0050482) | 2.68178967 |
| 62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.65028088 |
| 63 | response to radiation (GO:0009314) | 2.64928088 |
| 64 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.64403995 |
| 65 | mitochondrion transport along microtubule (GO:0047497) | 2.64403995 |
| 66 | post-embryonic morphogenesis (GO:0009886) | 2.64305337 |
| 67 | diterpenoid metabolic process (GO:0016101) | 2.52821766 |
| 68 | dopamine receptor signaling pathway (GO:0007212) | 2.49663890 |
| 69 | retinol metabolic process (GO:0042572) | 2.49018767 |
| 70 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.48980010 |
| 71 | negative regulation of cation channel activity (GO:2001258) | 2.45702532 |
| 72 | synaptic vesicle maturation (GO:0016188) | 2.45355459 |
| 73 | lipoprotein transport (GO:0042953) | 2.45152739 |
| 74 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.40289509 |
| 75 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.40289509 |
| 76 | behavioral response to cocaine (GO:0048148) | 2.40234596 |
| 77 | establishment of mitochondrion localization (GO:0051654) | 2.39321211 |
| 78 | synaptic transmission, dopaminergic (GO:0001963) | 2.38431135 |
| 79 | fatty acid elongation (GO:0030497) | 2.37689995 |
| 80 | positive regulation of cyclase activity (GO:0031281) | 2.36733476 |
| 81 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.33952294 |
| 82 | negative regulation of mast cell activation (GO:0033004) | 2.32512843 |
| 83 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.30960606 |
| 84 | terpenoid metabolic process (GO:0006721) | 2.30659805 |
| 85 | lactate metabolic process (GO:0006089) | 2.28675467 |
| 86 | sodium ion export (GO:0071436) | 2.24815515 |
| 87 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 19.8762423 |
| 88 | rhodopsin mediated signaling pathway (GO:0016056) | 19.4792832 |
| 89 | retinal cone cell development (GO:0046549) | 13.9332741 |
| 90 | photoreceptor cell maintenance (GO:0045494) | 12.5581955 |
| 91 | photoreceptor cell development (GO:0042461) | 12.0524337 |
| 92 | eye photoreceptor cell development (GO:0042462) | 11.4791115 |
| 93 | GMP metabolic process (GO:0046037) | 11.0030461 |
| 94 | phototransduction, visible light (GO:0007603) | 10.7645191 |
| 95 | detection of light stimulus involved in visual perception (GO:0050908) | 10.7246885 |
| 96 | detection of light stimulus involved in sensory perception (GO:0050962) | 10.7246885 |
| 97 | phototransduction (GO:0007602) | 10.6250497 |
| 98 | positive regulation of guanylate cyclase activity (GO:0031284) | 10.2686587 |
| 99 | detection of visible light (GO:0009584) | 10.2168454 |
| 100 | detection of light stimulus (GO:0009583) | 10.0635895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.56925876 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 5.02508288 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.24858878 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.08486930 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47285639 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26905482 |
| 7 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.16233663 |
| 8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92811607 |
| 9 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.90620142 |
| 10 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85616771 |
| 11 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.74677444 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73118569 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72743155 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68829398 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67501345 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63765791 |
| 17 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.61635907 |
| 18 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61035359 |
| 19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60088346 |
| 20 | AR_19668381_ChIP-Seq_PC3_Human | 1.56715436 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56612177 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52633595 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50647272 |
| 24 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49942221 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49418469 |
| 26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45922414 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41832185 |
| 28 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.41702473 |
| 29 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.37693403 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37006896 |
| 31 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35746986 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35231196 |
| 33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34507627 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32617938 |
| 35 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.30829113 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30142233 |
| 37 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30026990 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29096043 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25890295 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25504410 |
| 41 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.25464731 |
| 42 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.23850167 |
| 43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22876377 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.22513417 |
| 45 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22202621 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21872276 |
| 47 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.21216698 |
| 48 | TBL1_22424771_ChIP-Seq_293T_Human | 1.21140818 |
| 49 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20052025 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13420197 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.13300099 |
| 52 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.13178276 |
| 53 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12562816 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12314257 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12201264 |
| 56 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10621822 |
| 57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09968440 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09687459 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09580088 |
| 60 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.09518663 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07408512 |
| 62 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.07334249 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07333497 |
| 64 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06018431 |
| 65 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05429891 |
| 66 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05095260 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04010440 |
| 68 | CBP_21632823_ChIP-Seq_H3396_Human | 1.03509725 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01989246 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01273882 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01024229 |
| 72 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00716636 |
| 73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99967804 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99571848 |
| 75 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99431067 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99351557 |
| 77 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.98703446 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98639887 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97810777 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97432523 |
| 81 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.96899015 |
| 82 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96185261 |
| 83 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96135613 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93838408 |
| 85 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93829358 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92463801 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89585627 |
| 88 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.89421408 |
| 89 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88616556 |
| 90 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88516957 |
| 91 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87845574 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86639192 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86133190 |
| 94 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85704419 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85631448 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85572583 |
| 97 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.85210581 |
| 98 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.85210581 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84943478 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84018027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005253_abnormal_eye_physiology | 6.91920443 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 6.37053908 |
| 3 | MP0003950_abnormal_plasma_membrane | 4.89855202 |
| 4 | MP0005195_abnormal_posterior_eye | 3.94105016 |
| 5 | MP0002638_abnormal_pupillary_reflex | 3.70883455 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.55423553 |
| 7 | MP0005391_vision/eye_phenotype | 3.32752795 |
| 8 | MP0002090_abnormal_vision | 2.91212011 |
| 9 | MP0002229_neurodegeneration | 2.61910427 |
| 10 | MP0001764_abnormal_homeostasis | 2.56227482 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.32735218 |
| 12 | MP0003011_delayed_dark_adaptation | 10.5587435 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 10.1042047 |
| 14 | MP0002752_abnormal_somatic_nervous | 1.89435577 |
| 15 | MP0001986_abnormal_taste_sensitivity | 1.74011804 |
| 16 | MP0004233_abnormal_muscle_weight | 1.47023117 |
| 17 | MP0002882_abnormal_neuron_morphology | 1.36721143 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.30967594 |
| 19 | MP0002653_abnormal_ependyma_morphology | 1.14401931 |
| 20 | MP0001984_abnormal_olfaction | 1.03220071 |
| 21 | MP0001502_abnormal_circadian_rhythm | 1.02446763 |
| 22 | MP0004885_abnormal_endolymph | 0.94054587 |
| 23 | MP0005197_abnormal_uvea_morphology | 0.93618372 |
| 24 | MP0005187_abnormal_penis_morphology | 0.87997956 |
| 25 | MP0003634_abnormal_glial_cell | 0.87583449 |
| 26 | MP0004270_analgesia | 0.75894869 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 0.74487467 |
| 28 | MP0002332_abnormal_exercise_endurance | 0.70343947 |
| 29 | MP0001486_abnormal_startle_reflex | 0.70318677 |
| 30 | MP0002272_abnormal_nervous_system | 0.62135135 |
| 31 | MP0005376_homeostasis/metabolism_phenot | 0.60149574 |
| 32 | MP0001963_abnormal_hearing_physiology | 0.58401253 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 0.58134374 |
| 34 | MP0009046_muscle_twitch | 0.52139514 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 0.51097135 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 0.49618353 |
| 37 | MP0001286_abnormal_eye_development | 0.48727703 |
| 38 | MP0005499_abnormal_olfactory_system | 0.48278208 |
| 39 | MP0005394_taste/olfaction_phenotype | 0.48278208 |
| 40 | MP0005076_abnormal_cell_differentiation | 0.46807395 |
| 41 | MP0002064_seizures | 0.46527109 |
| 42 | MP0003045_fibrosis | 0.41400392 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 0.39868782 |
| 44 | MP0002067_abnormal_sensory_capabilities | 0.37734449 |
| 45 | MP0003880_abnormal_central_pattern | 0.36960903 |
| 46 | MP0002928_abnormal_bile_duct | 0.34952985 |
| 47 | MP0001661_extended_life_span | 0.34005496 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 0.33422297 |
| 49 | MP0004924_abnormal_behavior | 0.33031094 |
| 50 | MP0005386_behavior/neurological_phenoty | 0.33031094 |
| 51 | MP0000026_abnormal_inner_ear | 0.32991199 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 0.31394899 |
| 53 | MP0001968_abnormal_touch/_nociception | 0.31098975 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 0.30352049 |
| 55 | MP0002063_abnormal_learning/memory/cond | 0.29107227 |
| 56 | MP0006292_abnormal_olfactory_placode | 0.27523454 |
| 57 | MP0008569_lethality_at_weaning | 0.27508845 |
| 58 | MP0003252_abnormal_bile_duct | 0.27026136 |
| 59 | MP0003646_muscle_fatigue | 0.26754423 |
| 60 | MP0004085_abnormal_heartbeat | 0.26081824 |
| 61 | MP0005330_cardiomyopathy | 0.24788802 |
| 62 | MP0008961_abnormal_basal_metabolism | 0.24058159 |
| 63 | MP0003632_abnormal_nervous_system | 0.22802837 |
| 64 | MP0004215_abnormal_myocardial_fiber | 0.22281541 |
| 65 | MP0005620_abnormal_muscle_contractility | 0.22230596 |
| 66 | MP0001915_intracranial_hemorrhage | 0.21133167 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.19987157 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 0.19837538 |
| 69 | MP0002971_abnormal_brown_adipose | 0.19092002 |
| 70 | MP0008004_abnormal_stomach_pH | 0.18741922 |
| 71 | MP0009745_abnormal_behavioral_response | 0.17947424 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.17934211 |
| 73 | MP0001905_abnormal_dopamine_level | 0.17767736 |
| 74 | MP0003943_abnormal_hepatobiliary_system | 0.16187753 |
| 75 | MP0005360_urolithiasis | 0.15994739 |
| 76 | MP0004043_abnormal_pH_regulation | 0.15657468 |
| 77 | MP0004142_abnormal_muscle_tone | 0.14188166 |
| 78 | MP0002152_abnormal_brain_morphology | 0.13573342 |
| 79 | MP0002108_abnormal_muscle_morphology | 0.11806097 |
| 80 | MP0005334_abnormal_fat_pad | 0.11224885 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.11171797 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 0.10514519 |
| 83 | MP0004742_abnormal_vestibular_system | 0.09488318 |
| 84 | MP0005310_abnormal_salivary_gland | 0.09428233 |
| 85 | MP0003631_nervous_system_phenotype | 0.09394872 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.09138953 |
| 87 | MP0001614_abnormal_blood_vessel | 0.08979823 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.08783473 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.08771845 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.08557734 |
| 91 | MP0004811_abnormal_neuron_physiology | 0.08419181 |
| 92 | MP0000001_mammalian_phenotype | 0.08279287 |
| 93 | MP0004130_abnormal_muscle_cell | 0.08273384 |
| 94 | MP0005193_abnormal_anterior_eye | 0.07916172 |
| 95 | MP0001727_abnormal_embryo_implantation | 0.07849218 |
| 96 | MP0003633_abnormal_nervous_system | 0.07518488 |
| 97 | MP0003956_abnormal_body_size | 0.07368439 |
| 98 | MP0005266_abnormal_metabolism | 0.07157171 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.07102290 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.06899048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chorioretinal atrophy (HP:0000533) | 9.89717667 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.49550006 |
| 3 | Pigmentary retinal degeneration (HP:0001146) | 9.15466800 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 8.34831713 |
| 5 | Central scotoma (HP:0000603) | 8.16547318 |
| 6 | Scotoma (HP:0000575) | 7.62042918 |
| 7 | Pendular nystagmus (HP:0012043) | 7.53356799 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 7.36202229 |
| 9 | Dyschromatopsia (HP:0007641) | 7.16516693 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 6.31234901 |
| 11 | Decreased central vision (HP:0007663) | 5.97187550 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.94424156 |
| 13 | Photophobia (HP:0000613) | 5.78172689 |
| 14 | Cone-rod dystrophy (HP:0000548) | 5.65637672 |
| 15 | Keratoconus (HP:0000563) | 5.28052706 |
| 16 | Increased corneal curvature (HP:0100692) | 5.28052706 |
| 17 | Retinitis pigmentosa (HP:0000510) | 4.92955570 |
| 18 | Vitreoretinal degeneration (HP:0000655) | 4.75152620 |
| 19 | Choroideremia (HP:0001139) | 4.63821614 |
| 20 | Macular degeneration (HP:0000608) | 4.54684874 |
| 21 | Constricted visual fields (HP:0001133) | 4.41806681 |
| 22 | Posterior subcapsular cataract (HP:0007787) | 3.99608657 |
| 23 | Severe visual impairment (HP:0001141) | 3.88402453 |
| 24 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.82679511 |
| 25 | Retinal atrophy (HP:0001105) | 3.06639492 |
| 26 | Progressive visual loss (HP:0000529) | 3.04396079 |
| 27 | Optic disc pallor (HP:0000543) | 2.74254601 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 2.71677190 |
| 29 | Gait imbalance (HP:0002141) | 2.70236982 |
| 30 | Congenital primary aphakia (HP:0007707) | 2.67987166 |
| 31 | Wide nasal bridge (HP:0000431) | 2.63181064 |
| 32 | Subcapsular cataract (HP:0000523) | 2.43219392 |
| 33 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37376639 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.27812459 |
| 35 | Poor coordination (HP:0002370) | 2.03306187 |
| 36 | Congenital stationary night blindness (HP:0007642) | 14.8030733 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 13.1254047 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.0760081 |
| 39 | Vaginal atresia (HP:0000148) | 1.87571214 |
| 40 | Genital tract atresia (HP:0001827) | 1.78666828 |
| 41 | Optic atrophy (HP:0000648) | 1.71424158 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 1.68067561 |
| 43 | Horizontal nystagmus (HP:0000666) | 1.55684543 |
| 44 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.49341559 |
| 45 | Dysdiadochokinesis (HP:0002075) | 1.42642072 |
| 46 | Severe Myopia (HP:0011003) | 1.33497393 |
| 47 | Polar cataract (HP:0010696) | 1.30004283 |
| 48 | Astigmatism (HP:0000483) | 1.28107054 |
| 49 | Retinal detachment (HP:0000541) | 1.22763255 |
| 50 | Recurrent sinusitis (HP:0011108) | 1.18889235 |
| 51 | Cerebellar dysplasia (HP:0007033) | 1.18442480 |
| 52 | True hermaphroditism (HP:0010459) | 1.12785096 |
| 53 | Pancreatic fibrosis (HP:0100732) | 1.12183185 |
| 54 | Specific learning disability (HP:0001328) | 1.09884702 |
| 55 | Broad foot (HP:0001769) | 1.08599893 |
| 56 | Epileptic encephalopathy (HP:0200134) | 1.06705029 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 1.05066753 |
| 58 | Asthma (HP:0002099) | 1.04716725 |
| 59 | Decreased testicular size (HP:0008734) | 1.00512063 |
| 60 | Abnormality of the fovea (HP:0000493) | 1.00295853 |
| 61 | Truncal ataxia (HP:0002078) | 0.98869919 |
| 62 | Cystic liver disease (HP:0006706) | 0.96886295 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 0.95716443 |
| 64 | Pancreatic cysts (HP:0001737) | 0.93361303 |
| 65 | Hypoplasia of the fovea (HP:0007750) | 0.91528582 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 0.91528582 |
| 67 | Partial agenesis of the corpus callosum (HP:0001338) | 0.90202686 |
| 68 | Abnormality of dental color (HP:0011073) | 0.88712538 |
| 69 | Hypermetropia (HP:0000540) | 0.85638597 |
| 70 | Chorioretinal coloboma (HP:0000567) | 0.85586866 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 0.85077912 |
| 72 | Abnormality of midbrain morphology (HP:0002418) | 0.85077912 |
| 73 | Lymphopenia (HP:0001888) | 0.84765811 |
| 74 | Febrile seizures (HP:0002373) | 0.83688944 |
| 75 | Furrowed tongue (HP:0000221) | 0.80199563 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.79879953 |
| 77 | Dental crowding (HP:0000678) | 0.78870670 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.78453425 |
| 79 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.77615929 |
| 80 | Chronic hepatic failure (HP:0100626) | 0.76792722 |
| 81 | Abnormality of the fingertips (HP:0001211) | 0.76156347 |
| 82 | Macroorchidism (HP:0000053) | 0.74397342 |
| 83 | Short foot (HP:0001773) | 0.74380411 |
| 84 | Vertebral arch anomaly (HP:0008438) | 0.71983424 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 0.71290010 |
| 86 | Visual hallucinations (HP:0002367) | 0.69701073 |
| 87 | Hypodontia (HP:0000668) | 0.69596264 |
| 88 | Prolonged QT interval (HP:0001657) | 0.67718749 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 0.67474945 |
| 90 | Hirsutism (HP:0001007) | 0.66449508 |
| 91 | Heterotopia (HP:0002282) | 0.65545154 |
| 92 | Sclerocornea (HP:0000647) | 0.64917863 |
| 93 | Nephrotic syndrome (HP:0000100) | 0.64916962 |
| 94 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.64884433 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 0.62868800 |
| 96 | Postaxial hand polydactyly (HP:0001162) | 0.62802272 |
| 97 | Genetic anticipation (HP:0003743) | 0.59988386 |
| 98 | Nephronophthisis (HP:0000090) | 0.59777456 |
| 99 | Aqueductal stenosis (HP:0002410) | 0.59385588 |
| 100 | Prominent nasal bridge (HP:0000426) | 0.58919854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 8.41135206 |
| 2 | PINK1 | 2.87322773 |
| 3 | IRAK2 | 2.85517734 |
| 4 | SIK2 | 2.19332570 |
| 5 | GRK1 | 10.3579561 |
| 6 | MAP3K10 | 1.89825012 |
| 7 | CDK12 | 1.79376404 |
| 8 | MAPK12 | 1.78264122 |
| 9 | BRD4 | 1.66358389 |
| 10 | TAOK3 | 1.55263382 |
| 11 | MAPK7 | 1.37844612 |
| 12 | CAMK1G | 1.35554173 |
| 13 | PAK6 | 1.30311320 |
| 14 | ADRBK1 | 1.28692389 |
| 15 | FRK | 1.20483248 |
| 16 | MAP3K4 | 1.13151221 |
| 17 | PRKCH | 1.04009038 |
| 18 | HIPK2 | 1.01586402 |
| 19 | CSNK1D | 1.01333687 |
| 20 | CAMK1D | 0.99422657 |
| 21 | PRKD3 | 0.96696506 |
| 22 | PNCK | 0.92955091 |
| 23 | RPS6KA4 | 0.91659664 |
| 24 | PRKCZ | 0.88119351 |
| 25 | ICK | 0.84783423 |
| 26 | STK38 | 0.83049678 |
| 27 | DYRK1A | 0.81983957 |
| 28 | PRKAA2 | 0.79682871 |
| 29 | PRKAA1 | 0.79340006 |
| 30 | WNK1 | 0.77595243 |
| 31 | NEK2 | 0.75790871 |
| 32 | FES | 0.75088262 |
| 33 | SGK223 | 0.74962548 |
| 34 | SGK494 | 0.74962548 |
| 35 | SGK3 | 0.73253008 |
| 36 | SIK1 | 0.70303436 |
| 37 | SGK2 | 0.69682723 |
| 38 | INSRR | 0.65000552 |
| 39 | PHKG2 | 0.64460495 |
| 40 | PHKG1 | 0.64460495 |
| 41 | PRKCB | 0.64212113 |
| 42 | FGFR2 | 0.63857814 |
| 43 | CAMKK1 | 0.63252657 |
| 44 | TTK | 0.62803068 |
| 45 | PRKD2 | 0.60826462 |
| 46 | PRKACG | 0.60599279 |
| 47 | PAK3 | 0.60405994 |
| 48 | MAP3K7 | 0.59803283 |
| 49 | PKN1 | 0.57454668 |
| 50 | DYRK1B | 0.57051774 |
| 51 | CAMK2D | 0.57030736 |
| 52 | MARK1 | 0.56201712 |
| 53 | PDK2 | 0.55870011 |
| 54 | RPS6KA3 | 0.55499103 |
| 55 | MARK2 | 0.53534449 |
| 56 | NEK6 | 0.51965235 |
| 57 | STK11 | 0.49653592 |
| 58 | CAMK1 | 0.45421765 |
| 59 | AKT2 | 0.44773827 |
| 60 | AKT3 | 0.43965347 |
| 61 | TNK2 | 0.42723303 |
| 62 | MAPK9 | 0.41451372 |
| 63 | MKNK2 | 0.41392805 |
| 64 | GSK3B | 0.41081202 |
| 65 | PRKDC | 0.40058791 |
| 66 | ALK | 0.39861065 |
| 67 | MAPK14 | 0.39352957 |
| 68 | ERBB2 | 0.38823841 |
| 69 | CDK5 | 0.36770660 |
| 70 | ERN1 | 0.36225530 |
| 71 | SGK1 | 0.35679326 |
| 72 | PDK1 | 0.34236624 |
| 73 | EEF2K | 0.32552369 |
| 74 | CDK9 | 0.32332283 |
| 75 | CHUK | 0.31627549 |
| 76 | MAP2K4 | 0.31412540 |
| 77 | GRK5 | 0.30714794 |
| 78 | CDK1 | 0.30120379 |
| 79 | RPS6KB1 | 0.29151144 |
| 80 | PLK3 | 0.27284078 |
| 81 | MAPK3 | 0.27207031 |
| 82 | JAK1 | 0.27177837 |
| 83 | MAPK10 | 0.26254709 |
| 84 | CAMK4 | 0.26054155 |
| 85 | MAP3K13 | 0.25928629 |
| 86 | PRKACA | 0.25752594 |
| 87 | PRKCG | 0.25201894 |
| 88 | STK39 | 0.22416774 |
| 89 | MAPK8 | 0.22039995 |
| 90 | CSNK1E | 0.21268412 |
| 91 | CHEK1 | 0.21036527 |
| 92 | SCYL2 | 0.20803149 |
| 93 | SRC | 0.20311397 |
| 94 | MAPK4 | 0.19926296 |
| 95 | FGFR3 | 0.19706597 |
| 96 | PRKCA | 0.19322656 |
| 97 | CAMK2A | 0.18899269 |
| 98 | WNK4 | 0.18031455 |
| 99 | MAPK1 | 0.16919497 |
| 100 | MAP2K7 | 0.16555556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 16.1468888 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 1.53132913 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.31739882 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09150905 |
| 5 | Circadian rhythm_Homo sapiens_hsa04710 | 0.86683601 |
| 6 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84842432 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 0.82287380 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79617194 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79332646 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74126030 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70498853 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69348943 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68129987 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 0.64448295 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63475196 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63470544 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62337212 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49247394 |
| 19 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46471453 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45331829 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44011778 |
| 22 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43977290 |
| 23 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43818613 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40175156 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 0.39131436 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38040715 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37542111 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37227252 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 0.37044771 |
| 30 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32282823 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31396560 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30042134 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28613706 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28107425 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26802626 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26548415 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25931964 |
| 38 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25468994 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.24824967 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24719053 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24706050 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 0.24268970 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23792338 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.23318488 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23159362 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22861122 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22343475 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22296728 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21606722 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21513223 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20800971 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.19740009 |
| 53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19365528 |
| 54 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18546438 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.18427885 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18049323 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17751764 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17610865 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15831053 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15638511 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.15612570 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15471143 |
| 63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15173154 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14453601 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12778249 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.10635155 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.10548697 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.10387795 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.08868276 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08770849 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.08009534 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.07304719 |
| 73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.06762124 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.06670382 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06425761 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.06064083 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06036608 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.05621915 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05498342 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.05467701 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.05309418 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.05293777 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.05207483 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.04758389 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.04397206 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.04154289 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.04023846 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.02465913 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02414493 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.02176027 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.01825679 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.01801909 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01699458 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.01631633 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01459778 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.00822243 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.00765277 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.00506223 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.00491045 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00161139 |

